Werewolf Therapeutics (HOWL) Sees Strong Gains After IPO Debut
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/2/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
- Analysis-Excommunications show a Pope Leo unafraid of making firm decisions
- Whirlpool to close Mexico plant, expects $165M restructuring cost
- Meta Platforms stock surges 8% on cloud business plans
- Canaccord Starts Infleqtion, Inc (INFQ) at Buy
- Wall Street ends choppy session lower as tech shares drop
Werewolf Therapeutics (HOWL) IPO Opens 14% Higher
April 30, 2021 10:38 AM EDTToday's IPO for Werewolf Therapeutics, Inc. (NASDAQ: HOWL) opened for trading at $18.21 after pricing 7,500,000 shares of common stock at a public offering price of $16.00 per share.
Jefferies, SVB Leerink and Evercore ISI are acting as joint book-running managers for the offering.... More
Werewolf Therapeutics Inc. (HOWL) Prices 7.5M Share Upsized IPO at $16/Sh
April 30, 2021 5:42 AM EDTWerewolf Therapeutics, Inc. (NASDAQ: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the bodys immune system for the treatment of cancer, today announced the pricing of its upsized initial public offering of 7,500,000 shares of common stock at... More
